Advertisement

Picture Berlin Partner Top News Aignostics $43m AI Precision Medicine 650x100px
Organisation › Details

Rocket Pharmaceuticals Inc. (Nasdaq: RCKT)

Period Start 2015-01-01 established
  Group Rocket Pharmaceuticals (Group)
Product Industry gene therapy
Person Person Shah, Gaurav (Rocket Pharmaceuticals 202003 CEO)
     
Region Region New York, NY
  Country United States (USA)
  Street 350 Fifth Avenue
Empire State Building, Suite 7530
  City 10118 New York, NY
  Tel +1-646-440-9100
    Address record changed: 2020-12-02
     
Basic data Employees C: 51 to 100 (2020-03-02)
  Currency USD
  Profit -77,270,000 (2019-12-31)
  Cash 185,383,000 (2019-12-31)
     
     
   
Record changed: 2024-06-07

Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for Rocket Pharmaceuticals (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px




» top